Antiangiogenic properties of silver nanoparticles

Biomaterials

Volumn 30, Issue 31, 2009, Pages 6341-6350

  Gurunathan, Sangiliyandi ^a,b   Lee, Kyung Jin ^b   Kalishwaralal, Kalimuthu ^a   Sheikpranbabu, Sardarpasha ^a   Vaidyanathan, Ramanathan ^a   Eom, Soo Hyun ^b  

^a KALASALINGAM UNIVERSITY   (India)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Ag NPs; Angiogenesis; Bovine retinal endothelial cell; PEDF; Vascular endothelial growth factor

Indexed keywords

AG-NPS; ANGIOGENESIS; BOVINE RETINAL ENDOTHELIAL CELL; PEDF; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOACTIVITY; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; CELL PROLIFERATION; ENDOTHELIAL CELLS; NANOPARTICLES; OPHTHALMOLOGY; PATHOLOGY; PEPTIDES; SELF ASSEMBLY;

SILVER;

ANGIOGENESIS INHIBITOR; NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RETINA CELL; SIGNAL TRANSDUCTION;

ANGIOGENESIS INHIBITORS; ANIMALS; CATTLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SILVER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BOVINAE;

EID: 69649093476     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.08.008     Document Type: Article

References (47)

1. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?. Nat Med 6 (2000) 1102-1103
2. Cross M.J., and Claesson-Welsh L. FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22 (2001) 201-207
3. Boyer D., Antoszyk A., Awh C., Bhisitkul R., Shapiro H., and Acharya N. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 (2007) 246-252
4. Ogata N., Matsuoka M., Imaizumi M., Miyashiro M., Arichi M., Ando A., et al. Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy. Am J Ophthalmol 137 (2004) 935-936
5. Renno R.Z., Youssri A.I., Michaud N., Gragoudas E.S., and Miller J.W. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43 5 (2002) 1574-1580
6. Portney N.G., and Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 384 (2006) 620-630
7. Park G.E., and Webster T.J. A review of nanotechnology for the development of better orthopedic implants. J Biomed Nanotechnol 1 (2005) 18-29
8. Gojova A., Guo B., Kota R.S., Rutledge J.C., Kennedy I.M., and Barakat A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 115 3 (2007) 403-409
9. Frampton M.W., Stewart J.C., Oberdörster G., Morrow P.E., Chalupa D., Pietropaoli A.P., et al. Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect 114 1 (2006) 51-58
10. Rückerl R., Phipps R.P., Schneider A., Frampton M., Cyrys J., Oberdörster G., et al. Ultrafine particles and platelet activation in patients with coronary heart disease-results from a prospective panel study. Part Fibre Toxicol 4 (2007) 1
11. Boucher W., Stern J., Kotsinyan V., Kempuraj D., Papaliodis D., Cohen M., et al. Intravesical nanocrystalline silver decreases experimental bladder inflammation. J Urol 179 (2008) 1598-1602
12. Bhol K.C., and Schechter P.J. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci 52 (2007) 2732-2742
13. Xia X., Xiong S., Song W., Luo J., Wang Y., and Zhou R. Inhibition of retinal neovascularization by siRNA targeting VEGF165. Mol Vis 14 (2008) 1965-1973
14. Kalimuthu K., Babu R.S., Venkataraman D., Bilal M., and Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surf B 65 (2008) 150-153
15. Gurunathan S., David D., and Gerst J.E. Dynamin and clathrin are required for the biogenesis of a distinct class of secretory vesicles in yeast. EMBO J 21 (2002) 602-614
16. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183 (1996) 1161-1172
17. Ristorcelli E., Beraud E., Verrando P., Villard C., Lafitte D., Sbarra V., et al. Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J 22 (2008) 3358-3369
18. Banumathi E., Haribalaganesh R., Babu S.S.P., Kumar N.S., and Sangiliyandi G. High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels. Microvasc Res 77 (2009) 377-381
19. Roy A.M., Tiwari K.N., Parker W.B., Secrist III J.A., Li R., and Qu Z. Antiangiogenic activity of 4′-thio-β-d-arabinofuranosylcytosine. Mol Cancer Ther 5 (2006) 2218-2224
20. Yi T., Cho S., Yi Z., Pang X., Rodriguez M., Wang Y., et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 7 7 (2008) 1789-1796
21. Papakonstanti E.A., and Stournaras C. Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol Biol Cell 13 (2002) 2946-2962
22. Kalishwaralal K., Banumathi E., Pandian S.R.K., Deepak V., Muniyandi J., Eom S.H., et al. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloid Surf B 73 (2009) 51-57
23. Patan S. Vasculogenesis and angiogenesis. Cancer Treat Res 117 (2004) 3-32
24. Burgering B.M.T.H., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599-602
25. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81 (1995) 727-736
26. Mukherjee P., Bhattacharya R., Wang P., Wang L., Basu S., Nagy J.A., et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 11 (2005) 3530-3534
27. Murugesan S., Mousa S.A., O'Connor L.J., Lincoln II D.W., and Linhardt R.J. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett 581 (2007) 1157-1160
28. Shin S.H., Ye M.K., Kim H.S., and Kang H.S. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 7 13 (2007) 1813-1818
29. Thurman R.B., and Gerba C.H.P. The molecular mechanisms of copper and silver ion disinfection of bacteria and virus. Crit Rev Environ Control 18 (1989) 295-315
30. Greil J., Spies T., Böswald M., Bechert T., Lugauer S., Regenfus A., et al. Analysis of the acute cytotoxicity of the erlanger silver catheter. Infection 27 (1999) S34-S37
31. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 5425 (1999) 245-248
32. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci 92 (1995) 10457-10461
33. Miller J.W., Adamis A.P., Shima D.T., D'Amore P.A., Moulton R.S., O'Reilly M.S., et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145 3 (1994) 574-584
34. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
35. Volpert O.V., Zaichuk T., Zhou W., Reiher F., Ferguson T.A., Stuart P.M., et al. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8 4 (2002) 349-357
36. Cleaver O., and Melton D.A. Endothelial signaling during development. Nat Med 9 (2003) 661-668
37. Jiang B.H., Zheng J.Z., Aoki M., and Vogt P.K. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci 97 (2000) 1749-1753
38. Guo D., Jia Q., Song H.Y., Warren R.S., and Donner D.B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J Biol Chem 270 12 (1995) 6729-6733
39. Gerber H.P., Dixit V., and Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273 (1998) 13313-13316
40. Khwaja A., Rodriguez-Viciana P., Wennström S., Warne P.H., and Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16 10 (1997) 2783-2793
41. Chang H.W., Aoki M., Fruman D., Auger K.R., Bellacosa A., Tsichlis P.N., et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-Kinase. Science 276 5320 (1997) 1848-1850
42. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21 1 (1999) 99-102
43. Thompson J.E., and Thompson C.B. Putting the Rap on Akt. J Clin Oncol 22 20 (2004) 4217-4226
44. Chan T.O., Rittenhouse S.E., and Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68 (1999) 965-1014
45. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 (2000) 561-576
46. Thakker G.D., Hajjar D.P., Muller W.A., and Rosengart T.K. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 274 15 (1999) 10002-10007
47. Abedi H., and Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272 24 (1997) 15442-15451